Patients With Chronic HBV Treated With Entecavir, Tenofovir Disoproxil Fumarate Have Low HBsAg Seroclearance, Study Finds
June 24, 2021
Infectious Disease Advisor (6/23, Aghjayan), says “Patients with chronic hepatitis B virus (HBV) infection who are treated with entecavir or tenofovir disoproxil fumarate have been found to have low seroclearance of hepatitis B surface antigen (HBsAg),” a...